Cytosorbents
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.About CTSO
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.
CEOPhillip P. Chan
CEOPhillip P. Chan
Employees149
Employees149
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1997
Founded1997
Employees149
Employees149
CTSO Key Statistics
Market cap43.01M
Market cap43.01M
Price-Earnings ratio-3.58
Price-Earnings ratio-3.58
Dividend yield—
Dividend yield—
Average volume158.05K
Average volume158.05K
High today$0.70
High today$0.70
Low today$0.6541
Low today$0.6541
Open price$0.70
Open price$0.70
Volume131.08K
Volume131.08K
52 Week high$1.61
52 Week high$1.61
52 Week low$0.60
52 Week low$0.60
Stock Snapshot
With a market cap of 43.01M, Cytosorbents(CTSO) trades at $0.68. The stock has a price-to-earnings ratio of -3.58.
On 2025-12-27, Cytosorbents(CTSO) stock moved within a range of $0.65 to $0.70. With shares now at $0.68, the stock is trading +4.0% above its intraday low and -2.9% below the session's peak.
Trading activity shows a volume of 131.08K, compared to an average daily volume of 158.05K.
Over the past 52 weeks, Cytosorbents(CTSO) stock has traded between a high of $1.61 and a low of $0.60.
Over the past 52 weeks, Cytosorbents(CTSO) stock has traded between a high of $1.61 and a low of $0.60.
People also own
Based on the portfolios of people who own CTSO. This list is generated using Robinhood data, and it’s not a recommendation.